Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.

Saito M, Yu RK, Cheung NK.

Biochem Biophys Res Commun. 1985 Feb 28;127(1):1-7.

PMID:
2579648
3.
4.

Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.

Tai T, Kawashima I, Tada N, Dairiki K.

J Biochem. 1988 Apr;103(4):682-7.

5.

Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Longee DC, Wikstrand CJ, Månsson JE, He X, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD.

Acta Neuropathol. 1991;82(1):45-54.

PMID:
1659106
6.

Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.

Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA.

Cancer Res. 1989 Jun 1;49(11):2857-61.

7.

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.

Cheung NK, Canete A, Cheung IY, Ye JN, Liu C.

Int J Cancer. 1993 May 28;54(3):499-505.

PMID:
8509225
8.

A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.

Ye JN, Cheung NK.

Int J Cancer. 1992 Jan 21;50(2):197-201.

PMID:
1730513
10.
11.

Different reactivities of monoclonal antibodies to ganglioside lactones.

Tai T, Kawashima I, Tada N, Ikegami S.

Biochim Biophys Acta. 1988 Jan 19;958(1):134-8.

PMID:
3334863
12.

Production of monoclonal antibodies specific for ganglioside GD3.

Watarai S, Onuma M, Yasuda T.

J Biochem. 1991 Dec;110(6):889-95.

13.

Binding of monoclonal antibody A2B5 to gangliosides.

Kundu SK, Pleatman MA, Redwine WA, Boyd AE, Marcus DM.

Biochem Biophys Res Commun. 1983 Nov 15;116(3):836-42.

PMID:
6651849
14.

Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides.

Ozawa H, Kotani M, Kawashima I, Tai T.

Biochim Biophys Acta. 1992 Jan 24;1123(2):184-90.

PMID:
1371229
15.

DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.

Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewicz P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S, Kozbor D.

Cancer Res. 2005 Apr 15;65(8):3410-8.

16.

Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.

Heiss P, Bermatz S, Wehnes H, Heinzmann U, Senekowitsch-Schmidtke R.

Anticancer Res. 1997 Jul-Aug;17(4B):3145-7.

PMID:
9329622
17.

Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2.

Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee MB.

J Immunother. 1998 Jan;21(1):75-83.

PMID:
9456440
19.

Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.

Cheung NK, Neely JE, Landmeier B, Nelson D, Miraldi F.

J Nucl Med. 1987 Oct;28(10):1577-83.

20.

Cell-surface ganglioside GD2 in the immunohistochemical detection and differential diagnosis of neuroblastoma.

Sariola H, Terävä H, Rapola J, Saarinen UM.

Am J Clin Pathol. 1991 Aug;96(2):248-52.

Items per page

Supplemental Content

Write to the Help Desk